McDermott Will & Emery Advised Innate Pharma on the Framework of a Major Historic Agreement Between Innate Pharma and AstraZeneca for $ 1.2 billion - McDermott Will & Emery

McDermott Will & Emery Advised Innate Pharma on the Framework of a Major Historic Agreement Between Innate Pharma and AstraZeneca for $ 1.2 billion

Overview


McDermott lawyers from five offices advised Innate Pharma SA on its life sciences co-development and commercialization agreement with AstraZeneca and MedImmune. Legal team members included Emmanuelle Trombe and Anthony Paronneau (Paris), Rohan Massey (London), Sarah Hogan (Boston), Larry Guess and Alicia D’Alba (Chicago) and Carla Hine (Washington).